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ABSTRACT 
 
Envenomation is a serious public health and occupational hazard in tropical and subtropical 
countries. Antivenom serum treatment has been related to extreme hypersensitivity, high cost, and 
inaccessibility. Consequently, therapeutic plants have been investigated to give an alternative 
treatment. The aim of this study was to evaluate the ability of the methanolic extract and fractions 
of Tamarindus indica seeds to neutralize the hemolytic, anticoagulant and hemorrhagic activities of 
Bitis arietans venom. The powdered form of Tamarindus indica seed was extracted using 
methanol. The methanol extract was further fractionated using butanol solvent. The aqueous 
fraction of the methanolic extract inhibited hemolysis caused by crude venom by 95.5%, while 
methanolic extract significantly reduced the anticoagulant time of crude venom to 10.2%. The in 
vivo hemorrhagic activity of the crude venom of Bitis arietans was neutralized by both the crude 
methanolic extract and the subsequent two fractions of Tamarindus indica seed. However, the 
crude methanolic extract was found to be the most active by reducing the hemorrhage diameter 
caused by crude venom to 39%. The findings of this present research work demonstrated a very 
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good antivenom properties of the seeds of Tamarindus indica, which suggests that it could be a 
potential source of effective, and safe compounds with inhibitory activities against Bitis arietans 
envenomation. 
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ABBREVIATIONS 
 
ml  : Milliliter 
mM  : Millimolar 
mg  : Milligram 
PLA2  : Phospholipase A2 
CP  : Citrated plasma 
SVMP  : Snake Venom Metalloprotease 
RBC  : Red Blood Cell 
Aqu  : Aqueous fraction 
Butanol : Butanol fraction 
Meth  : Methanol extract 
V  : Venom 
MLD  : Mean Lesion Diameter 
WHO  : World Health Organization 
 
1. INTRODUCTION 
 
Snakebite is an important public health and 
occupational hazard often faced by farmers, farm 
laborers, hunters and nomads of tropical and 
subtropical countries present in Asia, Africa and 
South America [1]. Envenomation by venomous 
snake is a common acute life-threatening and 
time-limiting medical emergency. Globally, 
approximately 5.4 million snakebites occur each 
year, resulting in 1.8 to 2.7 million cases of 
envenomings, with mortality ranging from 81 410 
to 137 880 deaths and around three times as 
many amputations and other permanent 
disabilities each year [2,3]. The extent of 
snakebite globally, resulted the World Health 
Organization (WHO) declaration of snakebite as 
a neglected tropical disease in 2009. However, it 
was removed in 2013, and re-declared as 
category A on the 9th of June 2017 [4]. 
 
In Nigeria alone an estimate of 497 per 100,000 
populations are bitten annually by venomous 
snakes. Nigeria is therefore reported to have one 
fifth of all West African region cases of 
snakebites [5]. However, an accurate measure of 
snakebites remains elusive as most victims 
approach traditional healers for aid and 
treatment. Snakebite is a major challenge that 
affects farmers, nomads and rural dwellers of all 
ages. Inadequate facilities at the primary health 
center (PHC), ignorance of conventional 
treatment of snakebite by medical doctors; 
further delays inappropriate treatment of victims 
leads to increased morbidity and mortality [6]. 
Treatment with antivenom serum remains the 
only specific therapy for snakebite 
envenomation. However, it is heterologous and 
therefore liable to cause adverse reactions, such 
as early anaphylactic, pyrogenic and delayed 
reactions [7]. Medicinal plants are rich sources of 
natural inhibitors that tend to reduce the 
pharmacological activities of various snake 
venom without resulting to any side effects [8]. 
 
Bitis arietans commonly known as Puff adder is a 
venomous snake thought to be the most 
common and widespread snake in Africa, 
occurring throughout the continent except in 
some forested regions and extreme deserts such 
as the Sahara. Echis ocellatus is responsible for 
most snakebite incidence in Nigeria. Bitis 
arietans is third in terms of medical importance 
[9]. This is due to a combination of factors, 
including its wide distribution, common 
occurrence, large size, potent venom that is 
produced in large amounts, long fangs, and 
sitting quietly when approached. The venom has 
cytotoxic effects
 
and is one of the most toxic of 
any vipers based on LD50 [10]. Proteomic 
analyses has shown that hemorrghagins and 
hemolysins such as phospholipases A2, 
metalloproteases, serine proteases, disintegrins, 
L-amino acid oxidase, Kunitz inhibitors, cystatins 
and C-type lectins are present in Bitis arietans 
venom [11]. 
 
Tamarindus indica of the Fabaceae, subfamily 
Caesalpinioideae, is an important food in the 
tropics. It is a multipurpose tree of which almost 
every part finds at least some use either 
nutritional or medicinal [12]. Asian countries such 
as India and Myanmar have used Tamarindus 
indica for the treatment of snakebite and can be 
found in their traditional medicine book [13,14]. 
Therefore it is necessary to carry out scientific 
studies that demonstrate the use of the extract of 
these seeds in the treatment of snake bites. It 
has been noted that several anti snake venom 
activities are known to contain phenolic 
compounds [15]. 
 
Tamarind seeds are reported to contain phenolic 
antioxidants, procyanidins, epicatechin, taxifolin 
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and eriodictyol. This plant is readily available; 
therefore this will resolve the problems of 
accessibility, cost, and storage of antivenom 
immunotherapy treatment encountered by 
patients. Hence, the proper utilization of the 
antivenom properties of T. indica seed by 
researchers, could help provide an alternative 
treatment that would curb the challenges of 
envenomation in rural areas. 
 
The aim of this study was to determine the 
inhibitory effect of methanolic extract and 
fractions of Tamarindus indica seed on 
hemolytic, haemorrhagic and anticoagulant 
activities of crude venom of Bitis arietans. 
 
2. MATERIALS AND METHODS 
 
2.1 Chemicals and Reagents 
 
All solvents and All other chemicals: Sodium 
dihydrogen phosphate, Hydrogen disodium 
phosphate, sodium chloride, calcium chloride 
glycerol, Sodium hydroxide, sodium citrate were 
all purchased from Sigma Chemical Co. St. 
Louis, England and were of analytical grade. 
 
2.2 Venom Collection  
 
Two adult Bitis arietans were sourced from Fitika 
village, Giwa Local Government of Kaduna state, 
and allowed to acclimatize at the Herpetarium, 
Department of Veterinary Pharmacology and 
Toxicology, Ahmadu Bello University Zaria. The 
venom from the Bitis arietans was milked as 
described by Markfarlane [16]. 
 
2.3 Experimental Animals 
 
Male and female adult albino mice (20-30 g) of 
Swiss strain, were used for the research. The 
mice were procured from animal house of the 
Department of Pharmacology and Therapeutics 
Faculty of Pharmaceutical Sciences, Ahmadu 
Bello University, Zaria. 
 
2.4 Preparation of Plant Extract 
 
Tamarindus indica seed was obtained from 
Sabon-gari, Zaria, Kaduna State and then taken 
for identification at the Herbarium unit, with 
voucher number 602 at Department of Biological 
Sciences, Ahmadu Bello University Zaria. The 
dried seeds were crushed into fine powder. 
 
Dried powdered seeds of Tamarindus indica (1.2 
kg) was extracted for 75 hours using n-hexane, 
ethyl acetate, methanol solvent (2.5 L) 
successively by maceration following the 
procedure described by Sukito and Tachibana 
[17]. 
 
2.5 Fractionation of Extract of 
Tamarindus indica Seed 
 
The methanol seed extract (138.25 g) was 
dissolved in water (750 ml) and placed in a 
separating funnel and then 1.25 L of butanol was 
added mixed thoroughly and allowed to stand for 
24 hours. The butanol fraction was collected 
carefully subsequently the aqueous fraction. 
They were both dried using water bath at 40°c 
and then weighed. This procedure was carried 
out as described by Abubakar [18]. 
 
2.6 Hemolytic Assay of Crude Venom of 
Bitis arietans 
 
The method described by Gomes and Pallabi 
[19] was adopted using bovine erythrocytes to 
determine hemolytic activity. Twenty milliliters 
(20 ml) of bovine blood was collected from Zango 
abattoir, Zaria, Kaduna State, using sodium 
citrate as anticoagulant. A Thermo scientific 
sorvall primo R benchtop centrifuge was used to 
centrifuge blood sample at 646 x g for 10 min 
and the plasma discarded. Five milliliters (5 ml) 
of normal saline was mixed with the packed cell 
layer and centrifuged at 646 x g for 10 min and 
the supernatant discarded. This procedure was 
repeated 10 times to obtain plasma-free packed 
cells. Venom solution (5 mg/ml) was mixed with 1 
ml of 1% cell suspension in saline and the 
mixture was incubated at 37°C for 1 hr. the 
reaction was stopped by adding 3 ml of chilled 
phosphate buffer saline. Then centrifuged at 449 
x g for 10 mins and absorbance was measured 
at 540 nm using a Spectronic M508 
Spectrophotometer. For inhibitory studies 1ml 
venom solution, with 1 ml of 1% v/v cell 
suspension in saline was incubated with 1ml of 
different concentrations of plant extract fractions 
at 37°C for 1 hr. The reaction was also been 
stopped by adding 1ml of chilled phosphate 
buffer then centrifuged at 449 x g 10 min and 
absorbance was measured at 540 nm. The 
control sample consist of 1% cell suspension 
treated with 3 ml chilled water, was considered 
as 100% hemolysis. This assay was repeated 
three times in triplicates. 
 
% Inhibition of hemolysis = 100 x [OD1-
OD2/OD1] [20]. 
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Where: 
 
OD1 = Optical density of hypotonic saline   
solution alone 
OD2 = Optical density of test sample. 
 
2.7 Anticoagulant Activity Assay of Crude 
Venom of Bitis arietans 
 
Bovine blood sample of 20 ml was collected in 
3.8% sodium citrate, centrifuged at 701 x g and 
4°C for 2 hours to obtain platelet-poor plasma. 
Coagulant activity was measured by the method 
of Condrea et al. [21] using Bovine citrate plasma 
(2.0 mg/ml). Fifty microliters of CaCl2 (25 mM) 
was added then, 50 uL of venom was added to 
0.2 ml of citrated plasma solution and clotting 
time was recorded at 37°C. For inhibitory 
studies, 0.2 ml of citrated plasma solution was 
added to 1ml of CaCl2 (25 mM), then the venom 
alongside different concentrations of plant extract 
fraction. The mixture was incubated at 37°C for 2 
hours and the clotting time was recorded [22]. 
This assay was carried out three times in 
triplicates. 
 
2.8 Haemorrhagic Assay of Crude Venom 
of Bitis arietans 
 
The method described by Omori-Satoh et al. [23] 
was employed. Bitis arietans venom (5 mg/ml) 
was used where 0.2 ml was injected sub-
cutaneously into the backs of mice. The mice 
were sacrificed by cervical fracture after 60 min, 
and then skinned and the haemorrhagic foci was 
measured in mm. For inhibitory studies, the 
venom was injected alongside with different 
concentrations of plant extract and fractions into 
mice. The mice were sacrificed after 2 hours and 
the haemorrhagic foci was measured in mm as 
described by [23,24]. 
 
Thirty (30) mice were assembled and divided into 
5 groups of 6 mice each. (Male and female mice 
were evenly distributed in each group) 
 
Group 1: Untreated control was treated with 
normal saline. 
 
Group 2: Treated control was treated with 
Crude venom alone. 
 
Group 3: Treated with aqueous fraction and 
Crude Venom 
 
Group 4: Treated with n-butanol fraction and 
Crude Venom 
Group 5: Treated with methanolic extract and 
Crude Venom 
 
2.9 Statistical Analysis 
 
Experimental results were expressed as means ± 
SD. The data was analyzed by an analysis of 
variance (at p<0.05) and the means separated 
by Duncan’s multiple range tests. All statistical 
analysis was performed using coupled Microsoft 
Excel Software and; Statistical Package for 
Social Sciences (SPSS) version 20.0. 
 
3. RESULTS 
 
3.1 In vitro Studies Activity of Solvent 
Fractions of Tamarindus indica Seed 
Extracts on Crude Venom of Bitis 
arietans 
 
The hemolysis caused by distilled water was 
considered as 100% hemolysis of the RBC, 
which served as control. The hemolytic activity 
on RBC by the crude venom of Bitis arietans as 
shown in (Fig. 1) revealed a significantly high 
value of 65.8%±0.26. At the highest 
concentration of 10 mgml
-1
 the crude methanolic 
extract, butanolic fraction and aqueous fraction of 
T. indica seed incubated with 5mgml-1 of crude 
B. arietans venom significantly (at p<0.05) 
reduced hemolysis of RBC to 8.1%±2.51, 
11.7%±2.84 and 4.5%±2.62 respectively. At the 
least concentration of 2.5 mgml-1 the methanolic 
extract, butanolic fraction and aqueous fraction 
reduced hemolysis to 55.8%±1.85, 73.9%±4.56 
and 59.4%±1.11 respectively, suggesting that the 
methanolic extract, aqueous fraction and 
butanolic fraction T. indica seed protected the 
red blood cells from being lysed by toxins such 
as PLA2 present in Bitis aritans venom. 
 
The anticoagulant activity was carried out and 
the coagulation time was monitored for 2 hours. 
The crude venom of B. arietans did not yield clot 
formation after 2 hours of incubation, and this 
was considered 100% anticoagulation time as 
shown in (Fig. 2). Aqueous fraction, methanolic 
extract and butanolic fraction significantly 
reduced the anticoagulant time to 16.70±1.88%, 
10.21±0.62% and 47.53±1.61% respectively at 
10 mgml
-1
 concentration. While at the least 
concentration (2.5 mgml
-1
), aqueous fraction, the 
methanolic extract and butanolic fraction also 
significantly reduced the anticoagulant time to 
50.21±3.26%, 50.08±2.24% and 63.44±6.04% 
respectively, but not as compared to the highest 
concentration. 
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Fig. 1. Effect of T. indica seed extracts on the hemolytic properties of B. arietans venom 
Bars Represent the Mean ±SD: with different superscripts are significantly different at P < 0.05 by Duncan’s 
Multiple Range test 
 
 
Fig. 2. Effect of T. indica seed extracts on the anticoagulant properties of B. arietans venom 
Bars Represent the Mean ±SD: with different superscripts are significantly different at P < 0.05 by Duncan’s 
Multiple Range test 
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3.2 In vivo Activity of Solvent Fractions of 
Tamarindus indica Seed Extracts on 
Crude Venom of Bitis arietans 
 
The crude B. arietans venom resulted to an MLD 
of 32±3 mm, which was considered 100% 
hemorrhage. The methanolic extract, butanolic 
fraction, and aqueous fraction also significantly 
(at p < 0.05) reduce the diameter of lesion at 
high concentration to 39.1%±0.17, 40±0.1, and 
42.9±0.2 respectively as shown in (Fig. 3). This 
is to suggest that the crude methanolic extract, 
butanolic fraction and aqueous fraction of T. 
indica seed were able to reduce degradation of 
the capillary vessel in mice induced by PLA2 
isoform and crude venom of B arietans. 
 
4. DISCUSSION 
 
The antihemolytic activity implies that fractions of 
T. indica, especially aqueous consist of bioactive 
compounds that interfere with the mechanism, in 
which haemolysins such as PLA2 responsible for 
hemolysis present in the venom of Bitis arietans, 
interacts with phospholipids on cell membrane 
that results to hydrolysis of intact membrane 
releasing free fatty acids and lysopholipids 
[25,26,27].  
 
Medicinal plants have been recorded to 
deactivate proteins and peptides because of 
diverse secondary metabolite like polyphenols, 
terpenoids, and flavonoids which have been 
reported to neutralize snake venom 
[28,29,30,31]. Similar results were also shown by 
the methanolic extract of Indigofera pulchra and 
Aristolochia abida plants against hemolysis 
caused by Naja nigricollis venom [18]. This work 
conforms to findings of Ushanandini et al. [32], 
who reported that crude ethanolic extracts of      
T. indica were found to neutralize the hemolytic 
activity of Russelli viper. 
 
Anticoagulation and spontaneous bleeding are 
some of the hematological effects of viper 
envenomation in victims. These research study, 
revealed that treatment with the methanol crude 
extract and aqueous fraction neutralized the
  
 
 
Fig. 3. Effect of T. indica seed extracts on the haemorrhagic properties of B. arietans venom 
Bars Represent the Mean ±SD: with different superscripts are significantly different at P < 0.05 by Duncan’s 
Multiple Range test 
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anticoagulant effect of crude venom of B. 
arietans in a concentration dependent manner¸ 
where an increase in extract concentration 
reflected a significant reduction in anticoagulant 
activity of B. arietans venom. These findings 
suggest that the aqueous fraction constitute of 
bioactive compounds that inhibits haemolysins 
and haemorrhagic toxins. PLA2 is known to 
prevent the formation of the extrinsic tenase 
complex (TF, FVIIa and Ca2+) and the activation 
of FX to FXa required for the formation of 
prothrombinase complex, a vital component of 
blood coagulation [33,34]. It is worth noting that 
the activation of FX and prothrombin are both 
totally dependent on the presence of 
phospholipid membrane [35,36,37]. Aside from 
PLA2 in the venom of B. arietans, Zn
2+
 
metalloproteinase and other nonenzymatic toxins 
have been shown to degrade Aα and Bβ chains 
of fibrinogen and act upon the coagulation 
factors and complexes [38,1,39]. It is possible 
that bioactive compound present in aqueous 
fraction and crude methanolic extract of T. indica 
antagonize the anticoagulant activities of Zn
2+
 
metalloproteinase and other toxins in an 
unknown mechanism thereby preventing the 
hydrolysis of Aα and Bβ chains of fibrinogen. 
This work further authenticates the findings of 
Ushannidini et al. [32] who reported that the 
ethanolic extracts of T. indica was able to 
antagonize the defibrinogenating activity of V. 
russelli venom at a concentration of 25 ug. Other 
studies have shown that the aqueous extract of 
J. gossypiifolia at high concentration was able to 
inhibit fibrinogenolytic enzymes from B. jararaca 
by preventing the degradation of Aα and Bβ 
chains of fibrinogen [8]. 
 
Severe haemorrhage is a major challenge 
associated with envenomation of Bitis arietans. 
This study revealed that the crude venom of B. 
arietans induced a significantly high mean 
diameter of lesion in mice. This can be ascribed 
to the cumulative action of haemorrhagins such 
as, PLA2, Zn
2+ metalloprotease and 
nonenzymatic toxins present in B. arietans 
venom. However, irrespective of the cumulative 
effect of crude B. arietans venom, the methanolic 
extract and fractions of T. indica seed was still 
able to reduce hemorrhage. The reduction of 
haemorrhage by T. indica suggests that, it 
contains bioactive compounds that directly 
inhibits the major haemorrhagic toxins which are 
PLA2 and Zn
2+ metalloproteinase thus, 
preventing the degradation of the extracellular 
membrane components of the capillary vessels. 
It is possible that these bioactive compounds 
interacts with divalent ion such as Ca2+ and Zn2+ 
which are essential cofactors of PLA2 and SVMP 
respectively, thereby leading to the inhibition of 
their enzymatic activity.  
 
This findings, agrees with the report by 
Esmeraldino et al. [40] who showed that the 
butanolic fraction of C. urucurana plant was able 
to inhibit haemorrhage of B. jararaca venom by 
97%, which was ascribed to catechin, a basic 
unit of condensed tannins. Similar findings by 
Pithayannkul et al. [41] showed that the butanolic 
extract of Eclipta plant was able to neutralize the 
lethal and haemorrhagic effect of Malaysia pit 
viper venom and speculated that it could be due 
to the hydrogen interaction between the phenolic 
hydroxyls and the carbonyl group in the peptide 
bonds of the venom protein. 
 
5. CONCLUSION 
 
Viper envenomation is a major life-threatening 
event among healthy individuals in tropical and 
subtropical countries. In viper venoms, 
phospholipase A2 and proteases are extensively 
studied hydrolytic enzymes due to their relatively 
high abundance and participation in a wide range 
of pharmacological and toxic effects. 
 
The methanolic extract, aqueous fraction and 
butanolic fraction of T indica seed was able to 
neutralize the pharmacological activities of B. 
arietans which included hemolytic, anticoagulant 
and haemorrhagic effects which are key systemic 
and local effect in B. arietans envenomation. This 
indicates that methanolic extracts of T. indica 
seed consist of compounds that might interfere 
with the combined effects of the enzymes and 
toxins present in B. arietans venom. The findings 
of this present research work demonstrated a 
very good antivenom properties of the seeds of 
Tamarindus indica, which suggests that it could 
be a potential source of effective, safe and cost 
efficient antivenom agent for treatment of Bitis 
arietans envenomation. 
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